MP29-02: Clinical Trials

6 trials of MP29-02, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 withdrawn. 4 Phase 3, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4
Not applicable1Withdrawn 1
Phase 11Completed 1

Follow MP29-02: new trials by email Literature Review of MP29-02 trials Research Report on MP29-02

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone Propionate
MP29-02, Fluticasone propionate - Bioavailability Study
Not applicableWithdrawnUniversity Hospital, Ghent2016-08-012021-07-13
Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal Sprays
Azelastine, Fluticasone, Azelastine mono, Azelastine - Allergic Rhinitis
Phase 1CompletedMEDA Pharma GmbH & Co. KG302010-08-012022-02-07
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Placebo, azelastineHcl, fluticasone propionate - Seasonal Allergic Rhinitis
Phase 3CompletedMeda Pharmaceuticals17912009-04-012013-06-24
A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
azelastine HCl/fluticasone propionate, azelastine Hcl, fluticasone propionate - Seasonal Allergic Rhinitis
Phase 3CompletedMeda Pharmaceuticals7762008-08-012012-09-07
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Placebo, azelastine Hcl, azelastineHcl / fluticasone propionate - Seasonal Allergic Rhinitis
Phase 3CompletedMeda Pharmaceuticals8322008-03-012012-09-26
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
MP29-02, azelastine Hcl, fluticasone propionate - Seasonal Allergic Rhinitis
Phase 3CompletedMeda Pharmaceuticals6072007-12-012012-07-27

Conditions studied

Rhinitis, Allergic, Seasonal (4)  ·  Rhinitis, Allergic (1)

Sponsors

Meda Pharmaceuticals (4)  ·  MEDA Pharma GmbH & Co. KG (1)  ·  University Hospital, Ghent (1)

Countries

United States (4)  ·  Belgium (1)  ·  Germany (1)

Top investigators

Lewis M Fredane, MD (3)  ·  Christine Kolb (1)  ·  Claus Bachert (1)  ·  Lewis M. Fredane, MD (1)

Results publications

PMID 20674829

NIH funding

2015 (1)